Sanofi settles dispute with Genzyme investors over MS drug

Sanofi has settled a long-running dispute with shareholders in the biotech Genzyme, who claimed the big pharma deliberately held back development of a multiple sclerosis drug to avoid payme

J&J refutes FDA findings on asbestos in talc

Allergan pays $750m to avoid Alzheimer’s drug lawsuit

Major US retailers pull J&J's talc from shelves over asbesto...

A trio of major US retailers including Walmart are removing all 22-ounce bottles of Johnson & Johnson’s baby powder from their shelves after last week’s asbestos scare.

Lawsuit-laden J&J recalls baby powder after asbestos alert

Johnson & Johnson has said it is recalling around 33,000 bottles of baby powder in the US, after the FDA found tiny amounts of asbestos in samples taken from a bottle purchased online.<

J&J brushes off concerns over talc, opioid and Risperdal lit...

Johnson & Johnson has brushed off investors’ concerns over the many lawsuits it is facing, saying its legal team will overcome the litigation issues that have dominated headlines over t